GGrantIndex
Sort

172,184 grants matching inflammation

Clinical Epidemiology and Pathogenesis of Asymptomatic HSV

$2,535,398
Anna Wald · University Of Washington · P01 · FY2017 · AI

Contribution of bone marrow cells to tissue regeneration

$2,534,982
Eva M. Mezey · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE

EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROGRAM

$2,534,658
University Of Iowa · C06 · FY2003 · RR

Center for Mouse Genomic Variation at Single Cell Resolution

$2,534,261
Seyed Ali Mortazavi · University Of California-Irvine · UM1 · FY2023 · HG

Center for Mouse Genomic Variation at Single Cell Resolution

$2,534,261
Seyed Ali Mortazavi · University Of California-Irvine · UM1 · FY2022 · HG

Carbohydrate-based Therapy for Lung Disease

$2,534,255
John V Fahy · University Of California, San Francisco · P01 · FY2016 · HL

TAS::75 0872::TAS PROTEOMICS OF INFLAMMATION, IMNUNITY AND PULMONARY ARTERIAL HY

$2,533,866
Garry P Nolan · Stanford University · N01 · FY2010 · HL

Molecular and cellular mechanisms for bidirectional control of pain in the brain

$2,531,792
Yarimar Carrasquillo · National Center For Complementary & Integrative Health · ZIA · FY2024 · AT

Aging as a Risk Factor and Target for Prevention of Liver Cancer

$2,531,382
Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2021 · AG

Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure

$2,531,125
Lishomwa C Ndhlovu · Weill Medical Coll Of Cornell Univ · U01 · FY2023 · DA

Transforming Human Pancreatic Cancer Into An Immunologic Disease

$2,530,690
Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA

Transforming Human Pancreatic Cancer Into An Immunologic Disease

$2,530,688
Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA

Genetic and Cellular Determinants of Arterial Thrombosis

$2,530,472
Roy L Silverstein · Cleveland Clinic Lerner Com-Cwru · P50 · FY2006 · HL

Aging as a Risk Factor and Target for Prevention of Liver Cancer

$2,530,091
Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2025 · AG

Clinical Epidemiology and Pathogenesis of Asymptomatic HSV

$2,529,656
Anna Wald · University Of Washington · P01 · FY2015 · AI

Macrophages, Cell-Cell Communication, Ischemic Injury in Diabetes and the RAGE/DIAPH1 Signaling Axis

$2,529,082
Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2019 · HL

Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

$2,528,313
Alexander Bukreyev · University Of Texas Med Br Galveston · P01 · FY2022 · AI

Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes

$2,527,857
Andrew Scott Weyrich · University Of Utah · U54 · FY2015 · HL

Study of Women's Health Across the Nation (SWAN) V: Coordinating Center

$2,527,792
Maria Mori Brooks · University Of Pittsburgh At Pittsburgh · U01 · FY2015 · AG

Carbohydrate-based Therapy for Lung Disease

$2,527,018
John V Fahy · University Of California, San Francisco · P01 · FY2019 · HL

Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes

$2,526,974
Andrew Scott Weyrich · University Of Utah · U54 · FY2016 · HL

The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU)

$2,525,176
Charles W. Flexner · Johns Hopkins University · UM1 · FY2016 · AI

A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?

$2,525,060
Christopher K Glass · University Of California, San Diego · P01 · FY2021 · HL

Breast and Other Cancers in the California Teachers Cohort

$2,524,331
Leslie Bernstein · Beckman Research Institute/City Of Hope · R01 · FY2011 · CA

Genetic and Cellular Determinants of Arterial Thrombosis

$2,523,558
Roy L Silverstein · Cleveland Clinic Lerner Com-Cwru · P50 · FY2008 · HL